Last $35.97 USD
Change Today -1.07 / -2.89%
Volume 618.1K
BABY On Other Exchanges
Symbol
Exchange
Berlin
As of 5:20 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

natus medical inc (BABY) Snapshot

Open
$37.05
Previous Close
$37.04
Day High
$37.18
Day Low
$35.41
52 Week High
01/13/15 - $39.12
52 Week Low
04/15/14 - $21.54
Market Cap
1.2B
Average Volume 10 Days
160.9K
EPS TTM
$1.08
Shares Outstanding
32.5M
EX-Date
--
P/E TM
33.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for NATUS MEDICAL INC (BABY)

Related News

No related news articles were found.

natus medical inc (BABY) Related Businessweek News

No Related Businessweek News Found

natus medical inc (BABY) Details

Natus Medical Incorporated provides newborn care and neurology healthcare products worldwide. It offers healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn’s environment; and software systems for managing and tracking disorders and diseases for public health laboratories. It provides ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. The company also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, it provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, the company offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraint; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.

natus medical inc (BABY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $350.0K
Vice President and General Manager of Newborn...
Total Annual Compensation: $302.9K
Vice President and General Manager of Neurolo...
Total Annual Compensation: $265.0K
Vice President of Medical Affairs, Quality & ...
Total Annual Compensation: $257.0K
Compensation as of Fiscal Year 2013.

natus medical inc (BABY) Key Developments

Natus Medical Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Full Year 2015 and Full Year of 2016

Natus Medical Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported revenue of $94,010,000 compared to $90,636,000 a year ago. Income from operations was $14,099,000 compared to $14,415,000 a year ago. Income before tax was $14,597,000 compared to $13,136,000 a year ago. Net income was $9,920,000 or $0.30 per diluted share compared to $9,420,000 or $0.30 per diluted share a year ago. Non-GAAP income before provision for income tax was $17,517,000 compared to $16,331,000 a year ago. Non-GAAP net income was $13,118,000 or $0.40 per diluted share compared to $11,962,000 or $0.38 per diluted share a year ago. Non-GAAP operating profit was $17,019,000 compared to $17,610,000 a year ago. Non-GAAP Operating margin was 18.1% compared to 19.4% a year ago. For the year, the company reported revenue of $355,834,000 compared to $344,112,000 a year ago. Income from operations was $45,850,000 compared to $34,726,000 a year ago. Income before tax was $46,008,000 compared to $32,010,000 a year ago. Net income was $31,697,000 or $0.97 per diluted share compared to $23,325,000 or $0.76 per diluted share a year ago. Non-GAAP income before provision for income tax was $57,333,000 compared to $44,348,000 a year ago. Non-GAAP net income was $40,940,000 or $1.26 per diluted share compared to $32,144,000 or $1.04 per diluted share a year ago. Non-GAAP operating profit was $57,175,000 compared to $47,064,000 a year ago. Non-GAAP Operating margin was 16.1% compared to 13.7% a year ago. Cash flow from operations was about $8.5 million. For the first quarter of 2015, the company increased its revenue guidance to $88 million to $90 million, an increase from previous guidance of $87 million to $89 million, while non-GAAP earnings per share guidance remained unchanged at $0.28 to $0.30. The company updated its non-GAAP earnings guidance for the full year 2015 and now expects to report non-GAAP earnings per share of $1.42 to $1.46, an increase from previous guidance of $1.40 to $1.44. Full year 2015 revenue guidance was increased to $373 million to $375 million compared to previous guidance of $367 million to $369 million. The company's non-GAAP earnings guidance excludes amortization of acquisition related intangibles, acquisition related charges, restructuring charges, and their related tax effects. Non-GAAP earnings guidance includes the impact of expensing employee share based compensation. All non-GAAP earnings per share amounts are on a diluted basis. In 2015 goal is to achieve 18% operating profit for the full year. For the year 2016, the company expects to achieve 20% operating profit in 2016.

Natus Medical Seeks Acquisitions

Natus Medical Inc. (NasdaqGS:BABY) is seeking acquisitions. Jim Hawkins, President and Chief Executive Officer, said, "We did not have any large acquisitions in 2014 as we believed it was important to integrate our existing acquisitions and to show ourselves, shareholders and the medical community the strong leadership position that Natus has become and that we are a consistent, organic, growing and increasingly profitable business. With that said, acquisitions are an important part of our business model, and we look to pursue a meaningful acquisition in the latter part of 2015." Jim Hawkins added, "We are looking to do a significant acquisition at the end of this year. So we think we can do -- go both ways, and the internal teams that are driving the businesses are going to be doing that. At the corporate level, we will be driving the acquisition opportunities, and as you know, we are going to be disciplined as always."

Natus Medical Inc., Q4 2014 Earnings Call, Jan 28, 2015

Natus Medical Inc., Q4 2014 Earnings Call, Jan 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BABY:US $35.97 USD -1.07

BABY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $60.21 USD -0.01
NeuroMetrix Inc $1.64 USD -0.0132
NuVasive Inc $44.99 USD -0.51
Oxford Instruments PLC 768.50 GBp -7.50
View Industry Companies
 

Industry Analysis

BABY

Industry Average

Valuation BABY Industry Range
Price/Earnings 38.1x
Price/Sales 3.3x
Price/Book 3.3x
Price/Cash Flow 38.0x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATUS MEDICAL INC, please visit www.natus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.